NCT00627731View on ClinicalTrials.gov

Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Asthma
Interventions
DRUG

methylprednisolone sodium succinate (mPSL)

mPSL IV 240mg per day for 5 days and oral PSL 40mg per day for 5 days

DRUG

prednisolone (PSL)

PSL 40 mg per day for 10 days

Trial Locations (1)

Unknown

Hamamatsu University School of Medicine, Hamamatsu

All Listed Sponsors
lead

Hamamatsu University

OTHER

NCT00627731 - Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients | Biotech Hunter | Biotech Hunter